A New Category of Antibiotics May Present a Fresh Threat to Public HealthJune 13, 2003Bacteria have developed resistance to all antibiotics in use today, and this is causing a major health problem. However, a remarkable range of new antibiotics, called cationic antimicrobial peptides (AMPs), is attracting increasing interest as a key weapon in the fight against bacterial infection. They are based on toxic proteins that are part of the natural immune system of all animals, including humans. It is claimed that bacteria will be unable to evolve resistance to these defence proteins. Yet, "both experimental evidence and theoretical arguments suggest that this claim is doubtful", says Professor Graham Bell, from McGill University in Canada, who has reviewed the current research in this area for the June 2003 issue of Microbiology, a Society for General Microbiology journal. Some scientists claim that if these substances are used generally, then the bacteria may evolve resistance to these antimicrobial peptides that are part of the natural immune defences of the human body. This might threaten the normal operation of parts of the immune system in everyone, not only in the individuals treated. "This does not mean that they should not be developed", states Professor Bell, "but rather that their development should proceed with caution until we understand how the bacterial populations they will be used against would respond." The review is the first detailed explanation of why resistance is expected to evolve, and what the consequences would be for humans. It draws attention to the possible consequences of releasing a new category of antibiotics, before they have been properly tested. Professor Bell argues that "the evolutionary consequences of new clinical treatments involving the health of whole populations, present and future, should be considered in the regulatory process". Future experiments are needed to investigate the claim that bacteria will not evolve resistance to these new antibiotics. If these show that the claim is justified, then the path is clear for their development, and they can become a valuable resource in the struggle against infectious disease. If resistance does evolve, then further experiments will be needed to define safer pathways of development, in order to avoid longer-term dangers for the population as a whole. | |||||||||||||||||||||
|
Related Bacteria Current Events and Bacteria News Articles Misreading of damaged DNA may spur tumor formation The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses. Most of the time, our cells can repair the damage before it gets copied into a permanent mutation that could lead to cancer. Systems biology brings hope of speeding up drug development Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade. How Do Bacteria Swim? Brown Physicists Explain Imagine yourself swimming in a pool: It's the movement of your arms and legs, not the viscosity of the water, that mostly dictates the speed and direction that you swim. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Antibiotics Can Cause Pervasive, Persistent Changes to the Microbial Community in the Human Gut, MBL and Stanford Scientists Report Using a novel technique developed by Mitchell Sogin of the Marine Biological Laboratory (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial communities in the human gut respond to antibiotic treatment. Biomedical engineers' detective work reveals antibiotic mechanism A series of genetic clues led a team of Boston University biomedical engineers to uncover exactly how certain antibiotics kill bacteria. The findings could help rejuvenate the efficacy of older antibiotics and reveal new antibiotic targets within bacterial cells. Shifts in soil bacterial populations linked to wetland restoration success A new study led by Duke University researchers finds that restoring degraded wetlands -- especially those that had been converted into farm fields -- actually decreases their soil bacterial diversity. Forced evolution: Can we mutate viruses to death? It sounds like a science fiction movie: A killer contagion threatens the Earth, but scientists save the day with a designer drug that forces the virus to mutate itself out of existence. The killer disease? Still a fiction. The drug? It could become a reality thanks to a new study by Rice University bioengineers. Deep sea expedition sets sail Setting sail on the Pacific, a University of Delaware-led research team has embarked on an extreme adventure that will find several of its members plunging deep into the sea to study hydrothermal vents on the ocean floor. OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus. More Bacteria Current Events and Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||